Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Nanomaterials offer unique opportunities to modulate and enhance the functions of the body’s immune system, interacting with different immune cells to achieve specific effects. For example, they can be used in nanovaccine formulations that deliver antigens and adjuvants to the lymph nodes to stimulate the immune response against pathogens, that is, for B cell activation. On the other hand, they can also be used to suppress the immune reaction against transplanted organs and to curb the inflammatory response against self-antigens in autoimmune diseases, by reprogramming dendritic cells to a tolerogenic phenotype. Moreover, by interacting with different subtypes of T cells, in vivo and ex vivo, nanomaterials present many opportunities to advance nanomedicine in the area of cancer immunotherapy, especially if the multiple environmental and host-related factors that may alter immune responses are taken into consideration to design preclinical experiments suited for clinical translation. On the cover, an artistic impression represents nanomaterials interacting with various immune cells such as T cells and dendritic cells to boost their antitumour responses.
Flexibly designed nanomaterials can trigger specific immune responses and might offer promising alternatives to traditional immunosuppressive therapies, cancer immunotherapies and vaccine formulations.
Ultrafast spectroscopy measurements present a new direct non-equilibrium energy transfer mechanism across a metal–semiconductor interface, without charge transfer, opening up a new avenue for plasmonic energy conversion.
Compared to cancer nanomedicine, cancer immune nanomedicine presents unique challenges stemming from the complexity of the tumour responses to immunotherapy. This Perspective describes some of the factors contributing to this complexity and offers thoughts on how nanomedicine researchers can include them in their experimental design.
This Review provides an overview of the advantages and disadvantages of nanoscale vaccines against infectious diseases, focusing in particular on the immunological responses they can elicit, depending on their physicochemical properties and functionalization, and on the challenges their production face.
Tolerogenic dendritic cells inhibit inflammatory responses against self-antigens, offering a therapeutic strategy for autoimmune diseases. This Review describes the nanotechnology-based approaches available to target dendritic cells and induce tolerogenic properties, highlighting applications in organ transplantation, multiple sclerosis and diabetes mellitus.
An energy transduction mechanism across metal/semiconductor interfaces, which relies on electron–electron energy transfer rather than the transport of charge, is demonstrated through ultrafast infrared spectroscopy. This ballistic thermal injection process allows for extended modulation of plasmonic absorption in epsilon-near-zero media.
Optical reflectance spectroscopy provides a direct observation of layer-hybridized moiré excitons in angle-aligned transition metal dichalcogenide heterostructures.
A combination of atomistic imaging and spectroscopy reveals that metal substitution into a sulfur vacancy is the underlying mechanism for resistive switching in transition metal dichalcogenide monolayers.
Two-dimensional electronic spectroscopy reveals the existence of intermolecular conical intersections in molecular aggregates relevant for photovoltaics.
By controlling two voltage gates separately from one another, a spatial light modulator has been made that can continuously vary the phase of 360 degrees while independently adjusting the amplitude.
Metal–organic frameworks form a permselective membrane that prevents the migration of redox species in organic batteries, resulting in enhanced cyclability.
Chemoresistant cancer stem-like cells (CSCs) can be selectively killed by a nanoparticle, which releases an agent under hypoxic conditions that induces CSC differentiation, and a chemotherapeutic drug in response to reactive oxygen species in differentiating CSCs.